Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Semnur Pharmaceuticals, Inc. has filed 210 SEC EDGAR filings since 01 Mar 2022

SEC filing history

Showing 101-125 of 210 matching filings.

Per page
25
Current page
5
425 File 001-41351

425

Filing date
11 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
11 Oct 2024
Reporting date
11 Oct 2024
Next action
Verify source filing
SC 13G/A File 005-93795

SC 13G/A

Filing date
07 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-41351

425

Filing date
07 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
07 Oct 2024
Reporting date
02 Oct 2024
Next action
Verify source filing
SC 13G/A File 005-93795

AMENDMENT NO. 1 TO SCHEDULE 13G

Filing date
16 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Sep 2024
Reporting date
30 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Sep 2024
Reporting date
30 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-41351

CURRENT REPORT

Filing date
12 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
12 Sep 2024
Reporting date
11 Sep 2024
Next action
Verify source filing
SC 13D File 005-93795

SC 13D

Filing date
09 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-41351

CURRENT REPORT

Filing date
05 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
05 Sep 2024
Reporting date
30 Aug 2024
Next action
Verify source filing
10-Q File 001-41351

QUARTERLY REPORT

Filing date
19 Aug 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
NT 10-Q File 001-41351

NT 10-Q

Filing date
14 Aug 2024
Reporting date
30 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-41351

CURRENT REPORT

Filing date
09 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
09 Aug 2024
Reporting date
09 Aug 2024
Next action
Verify source filing
SC 13G File 005-93795

SC 13G filing

Filing date
09 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
17 Jul 2024
Reporting date
15 Jul 2024
Next action
Verify source filing
425 File 001-41351

CURRENT REPORT

Filing date
10 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
10 Jul 2024
Reporting date
10 Jul 2024
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
05 Jul 2024
Reporting date
02 Jul 2024
Next action
Verify source filing
DEF 14A File 001-41351

PROXY STATEMENT

Filing date
28 Jun 2024
Reporting date
10 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
27 Jun 2024
Reporting date
26 Jun 2024
Next action
Verify source filing
PRE 14A File 001-41351

PROXY STATEMENT

Filing date
18 Jun 2024
Reporting date
18 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .